July 9th 2025
Older patients with small cell lung cancer and significant weight loss were more likely to experience dose interruptions than patients with cachexia.
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
ASCO's TAPUR Study Expands to Enroll Patients Receiving Immunotherapy
FDA Action on MSK Tumor Profiling Assay Breaks Ground on Multiple Fronts
Dr Amy Abernethy on Improving Patient Access to Oncology Clinical Trials